Skip to content
Review

Animal models of autism spectrum disorder: Bridging biology to behaviour.

Aug 2026 · Developmental Medicine & Child Neurology · 0 citations · 83 references
Medicine

TL;DR

The framework used to evaluate the relevance of animal models-construct, face, and predictive validity-is outlined and the behavioural paradigms used to assess core ASD-related domains in rodents are summarized, including social interaction and communication, restricted and repetitive behaviours, and cognitive flexibility.

Abstract

The prevalence of autism spectrum disorder (ASD) has risen over the decades, reflecting improved awareness and evolving diagnostic practice. ASD is characterized by clinical and biological heterogeneity, with diverse genetic and environmental risk factors converging on disruption of synaptic function, circuits, and behaviour. This complexity limits mechanistic inference from human studies and underscores the importance of animal models for establishing causal relationships between risk mechanisms and ASD-relevant phenotypes. In this review, we outline the framework used to evaluate the relevance of animal models-construct, face, and predictive validity-and summarize the behavioural paradigms used to assess core ASD-related domains in rodents, including social interaction and communication, restricted and repetitive behaviours, and cognitive flexibility. We then examine mouse models of ASD, encompassing genetically engineered lines and inbred and idiopathic strains, discussing their mechanistic contributions, limitations, and sources of phenotypic variability. In addition, we briefly review environmental models and complementary animal species, which provide insights into distinct aspects of ASD biology. Collectively, the available models reveal convergent molecular and circuit mechanisms underlying ASD-related phenotypes. When interpreted within a framework and supported by standardized behavioural and physiological approaches, these models constitute a powerful platform for elucidating ASD pathophysiology and for guiding the preclinical development of targeted therapeutic strategies.

View source

Similar papers

Review Open access Jul 2026

From heterogeneity to translation: data‑driven subtyping of autism in a multilevel framework.

Advances in data-driven approaches to parsing ASD heterogeneity are synthesized and a simple one-to-one correspondence between behavioral and neural subtypes are argued; instead, the evidence is more consistent with multi-to-one, one-to-many, or many-to-many mappings that converge on the overall functional impairment.

Xingke Wang, Zhou Zhang, Shuang Li et al. · 0 citations
Review Open access Aug 2026

Gene Therapy for Autism Spectrum Disorder: Preclinical Advances, Translational Barriers, and Ethical Dimensions - A Scoping Review.

Gene therapy for ASD shows considerable promise but faces significant translational and ethical hurdles and standardized study designs, comprehensive safety evaluation, and transparent stakeholder engagement will be critical for developing responsible and effective clinical applications.

Ali Naderi Malek, Amir Hossein Rasoli Jokar, Patricia A. Prelock · 0 citations
Review Aug 2026

Heterogeneity in autism - challenges and opportunities.

Report from the 2021 Lancet Commission on autism recommends that research should focus on improving quality of life through personalized assessment and intervention, and that gene therapy may offer future therapeutic options.

Xiang Yu · 0 citations
Open access Jul 2026

Cortical Network Overconnectivity Relates to Sensory, Cognitive, and Social Dimensions in Young Children With Autism Spectrum Disorder.

RCCA revealed three distinct FC patterns in recurrent ASD-related networks, each contributing to predict individual differences in cognitive, social and sensory features, which may shed light on atypical brain network topology associated with specific phenotypic manifestations of ASD.

B. Rodríguez-Herreros, A. Mheich, J. A. Osório et al. · 0 citations
Open access Jul 2026

Sex-specific neurological dysregulation may underpin distinctly different male and female behavioural phenotypes in a zebrafish model of autism spectrum disorder.

Using a preclinical in vivo model of idiopathic ASD, distinct neurotransmitter mechanisms elucidated may potentially warrant the consideration of sex-specific therapeutic targets in the ASD context.

L. Pretorius, Tamera Moodley, Carine Smith · 0 citations
Review Open access Aug 2026

Somatic, Psychiatric and Neurodevelopmental Comorbidities in People with Autism Spectrum Disorder (ASD): A Narrative Review

A narrative review of papers published between 1 January 2015 and 16 February 2026 that were pertinent to comorbidity and autism finds how the variable risk of comorbidity mimics the heterogeneity present in autism, thus inviting further investigations.

E. Dando, Juergen Hahn, D. Geier et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.